ARBLI FDA approval date

The FDA approved ARBLI on 13 Mar 2025.

FDA approval date
13 Mar 2025

Drug identity has not yet been verified against registry records

Also recorded as LOSARTAN POTASSIUM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-03-13DayARBLIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA218772", "applicant_as_listed_by_fda": "SCIENTURE", "brand_names": ["ARBLI"], "active_ingredients": ["LOSARTAN POTASSIUM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20250313", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026